Latest Shareholder Capital News

Wiluna Mining is asking investors to fund an $180 million relisting and mine-restart plan after a processing-tank rupture halted its revenue-generating operations. The company delivered a $59.5 million FY26 profit, but its prospectus warns that near-term gold sales are not expected and the restart remains unproven.

Regener8 Resources has completed the sale of its Kookynie Gold Project to Goldarc Resources for initial consideration of A$1.5 million in escrowed shares, with up to a further A$1 million tied to future resource milestones. The deal leaves Regener8 focused on its Srebrenica North silver-zinc-lead-antimony project in Bosnia and Herzegovina.

Genetic Signatures says its existing directors will resign if BCAL nominees become a majority after the 28 October EGM. The company is also demanding clarity on whether BCAL intends to merge with GSS, pointing to the stark difference between the two companies’ cash runways.

Perpetual Resources and adviser GreenMet are assessing several US Government funding and financing pathways for the Nevada Scheelite tungsten project, as Washington prepares tighter defence sourcing rules. The interest is strategic, but no funding has been secured and the project remains without a Mineral Resource or Ore Reserve.

4DS Memory Limited is raising nearly $3 million through a pro-rata entitlement issue as part of a broader $5 million capital raise to acquire AI software firm Jenesys and integrate it with its ReRAM technology.

Alterity Therapeutics has arranged an underwriting deal for up to 8.4 million ATHO options, potentially raising A$4.2 million to A$7.96 million ahead of their expiry. The funds aim to support the upcoming Phase 3 trial for ATH434 in Multiple System Atrophy and bolster working capital.

Micro-X Limited lifted revenues by 16% to $15.1 million for FY26 but posted a $9.9 million net loss, narrowing from the prior year. The company advanced key medical imaging milestones and initiated a strategic reset to sharpen commercial focus and reduce costs.

Rua Bioscience's FY26 results highlight a 71% surge in customer revenue driven by international expansion, yet the company continues to face significant losses and going concern risks.

Deep Yellow Limited has locked in two pivotal agreements for its Tumas uranium project in Namibia, securing long-term water supply and formalising local ownership with Oponona Investments. These milestones pave the way for construction progress and a Final Investment Decision expected later this year.

WAM Leaders Limited (ASX:WLE) delivered a stellar FY2026 with net profit after tax soaring 153.5% to AUD 161.8 million, driven by a 14% investment portfolio gain that outpaced the ASX 200 by 7.9%. The company declared a fully franked full year dividend of 9.6 cents per share, maintaining a strong yield amid ongoing capital raising.

Avenira Ltd (ASX:AEV) is raising nearly $49 million through a heavily discounted three-for-two renounceable rights issue to finance the transition of its Wonarah Phosphate Project from development to production.

GoldArc Resources has delivered its strongest gold intercept at Mt Stirling Well, reinforcing high-grade continuity and advancing mine planning under a fully funded drilling program.